These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35302756)

  • 41. Utilization of the CRISPR/Cas9 system for the efficient production of mutant mice using crRNA/tracrRNA with Cas9 nickase and FokI-dCas9.
    Terao M; Tamano M; Hara S; Kato T; Kinoshita M; Takada S
    Exp Anim; 2016 Jul; 65(3):275-83. PubMed ID: 26972821
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CRISPR-Cas9 based plant genome editing: Significance, opportunities and recent advances.
    Soda N; Verma L; Giri J
    Plant Physiol Biochem; 2018 Oct; 131():2-11. PubMed ID: 29103811
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Advances of CRISPR/Cas9 activation system].
    Ding X; Pan Z; Yang L; Luo X; Jiang N; Zhu M; Wu C; Lan G; Li P
    Sheng Wu Gong Cheng Xue Bao; 2022 Aug; 38(8):2713-2724. PubMed ID: 36002405
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CRISPR/Cas9-mediated targeted mutagenesis of GmSPL9 genes alters plant architecture in soybean.
    Bao A; Chen H; Chen L; Chen S; Hao Q; Guo W; Qiu D; Shan Z; Yang Z; Yuan S; Zhang C; Zhang X; Liu B; Kong F; Li X; Zhou X; Tran LP; Cao D
    BMC Plant Biol; 2019 Apr; 19(1):131. PubMed ID: 30961525
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent advances in CRISPR/Cas9-mediated knock-ins in mammalian cells.
    Banan M
    J Biotechnol; 2020 Jan; 308():1-9. PubMed ID: 31751596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High content analysis platform for optimization of lipid mediated CRISPR-Cas9 delivery strategies in human cells.
    Steyer B; Carlson-Stevermer J; Angenent-Mari N; Khalil A; Harkness T; Saha K
    Acta Biomater; 2016 Apr; 34():143-158. PubMed ID: 26747759
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development and Applications of CRISPR/Cas9-Based Genome Editing in
    Mu Y; Zhang C; Li T; Jin FJ; Sung YJ; Oh HM; Lee HG; Jin L
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361647
    [No Abstract]   [Full Text] [Related]  

  • 48. Boosting targeted genome editing using the hei-tag.
    Thumberger T; Tavhelidse-Suck T; Gutierrez-Triana JA; Cornean A; Medert R; Welz B; Freichel M; Wittbrodt J
    Elife; 2022 Mar; 11():. PubMed ID: 35333175
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CRISPR/Cas9-Based Genome Editing of Transcription Factor Genes in Marchantia polymorpha.
    Sugano SS; Nishihama R
    Methods Mol Biol; 2018; 1830():109-126. PubMed ID: 30043367
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current status of potential applications of repurposed Cas9 for structural and functional genomics of plants.
    Seth K; Harish
    Biochem Biophys Res Commun; 2016 Nov; 480(4):499-507. PubMed ID: 27955725
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A CRISPR-dCas Toolbox for Genetic Engineering and Synthetic Biology.
    Xu X; Qi LS
    J Mol Biol; 2019 Jan; 431(1):34-47. PubMed ID: 29958882
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Advances of CRISPR/dCas9 system in live cell imaging].
    Lin S; Zhong X; Ma L; Qiao J; Liu Y
    Sheng Wu Gong Cheng Xue Bao; 2021 Sep; 37(9):3061-3070. PubMed ID: 34622617
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapid and reversible epigenome editing by endogenous chromatin regulators.
    Braun SMG; Kirkland JG; Chory EJ; Husmann D; Calarco JP; Crabtree GR
    Nat Commun; 2017 Sep; 8(1):560. PubMed ID: 28916764
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CRISPR/dCas system as the modulator of gene expression.
    Kazi TA; Biswas SR
    Prog Mol Biol Transl Sci; 2021; 178():99-122. PubMed ID: 33685602
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The new normal of structure/function studies in the era of CRISPR/Cas9.
    Logsdon GA; Black BE
    Biochem J; 2018 May; 475(9):1635-1642. PubMed ID: 29764955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cell-specific CRISPR-Cas9 activation by microRNA-dependent expression of anti-CRISPR proteins.
    Hoffmann MD; Aschenbrenner S; Grosse S; Rapti K; Domenger C; Fakhiri J; Mastel M; Börner K; Eils R; Grimm D; Niopek D
    Nucleic Acids Res; 2019 Jul; 47(13):e75. PubMed ID: 30982889
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent Progress and Future Prospect of CRISPR/Cas-Derived Transcription Activation (CRISPRa) System in Plants.
    Ding X; Yu L; Chen L; Li Y; Zhang J; Sheng H; Ren Z; Li Y; Yu X; Jin S; Cao J
    Cells; 2022 Sep; 11(19):. PubMed ID: 36231007
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prime editing in plants and mammalian cells: Mechanism, achievements, limitations, and future prospects.
    Hillary VE; Ceasar SA
    Bioessays; 2022 Sep; 44(9):e2200032. PubMed ID: 35750651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Notes on Functional Modules in the Assembly of CRISPR/Cas9-Mediated Epigenetic Modifiers.
    Kondrashov A; Karpova E
    Methods Mol Biol; 2021; 2198():401-428. PubMed ID: 32822047
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeted genome regulation via synthetic programmable transcriptional regulators.
    Piatek A; Mahfouz MM
    Crit Rev Biotechnol; 2017 Jun; 37(4):429-440. PubMed ID: 27093352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.